J2920 HCPCS code: Injection, methylprednisolone sodium succinate, up to 40 mg
J2920 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 40 mg. CMS terminated J2920 on 2024-03-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $2.89 per service for J2920 across 29,027 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. Medicare volume fell 76% from 2022 to 2024 (120,760 to 29,027 services). In 2024, about 4,326 clinicians billed Medicare for J2920 for 13,617 beneficiaries; Florida, California, Texas accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 2024-04-01 |
| Terminated | 2024-03-31 |
Who bills J2920 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,326 |
| Medicare beneficiaries | 13,617 |
| States with claims | 45 |
| Share of services in top 3 states (Florida, California, Texas) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2920, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 120,760 | 42,196 | $4.13 | $3.19 |
| 2023 | 118,803 | 40,366 | $3.86 | $2.97 |
| 2024 | 29,027 | 13,617 | $4.07 | $2.89 |
States with the most J2920 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 6,543 | $3.01 |
| California | 3,315 | $3.00 |
| Texas | 2,317 | $2.86 |
| Arizona | 1,333 | $2.88 |
| Georgia | 1,332 | $2.68 |
What changed for J2920
- 1982-01-01: J2920 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2920?
J2920 is the HCPCS Level II code for injection, methylprednisolone sodium succinate, up to 40 mg. Short descriptor: "Methylprednisolone injection".
How much does Medicare pay for J2920?
In 2024, the average Medicare payment was $2.89 per service (average allowed $4.07).
Does Medicare cover J2920?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
Related J29 codes
- J2910 — Injection, aurothioglucose, up to 50 mg
- J2916 — Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg
- J2919 — Injection, methylprednisolone sodium succinate, 5 mg
- J2930 — Injection, methylprednisolone sodium succinate, up to 125 mg
- J2940 — Injection, somatrem, 1 mg
- J2941 — Injection, somatropin, 1 mg
- J2950 — Injection, promazine hcl, up to 25 mg
- J2993 — Injection, reteplase, 18.1 mg
- J2995 — Injection, streptokinase, per 250,000 iu
- J2997 — Injection, alteplase recombinant, 1 mg
- J2998 — Injection, plasminogen, human-tvmh, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2920
- Watch J2920 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2920
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.